Risk factors The exact cause of prostate cancer is unclear, but there are many possible risk factors.
Age Prostate cancer is rare among men under prostate reduction the age of 45 years, but more common after the age of 50 years. Geography Prostate cancer occurs most frequently in North America, northwestern Prostate gleason score Europe, on the Caribbean islands, and in Australia.
Genetic factors Certain genetic and prostate reduction ethnic groups have an increased risk of prostate reduction prostate cancer. In the U. S., prostate cancer Prostate reduction is at least 60 percent more common prostate reduction and 2 to 3 times more deadly among black men than non-Hispanic white men. A Prostate reduction man also has a much higher risk of developing cancer if his identical twin prostate reduction has it, and a man whose brother or father had prostate cancer has twice the risk of developing it compared to other men. Having a brother who has or has had prostate cancer is more of a genetic risk than having a father with the disease. Diet Studies have suggested that a prostate reduction diet high in red meat or high-fat dairy products Prostate urethra may increase a person's chances of developing prostate cancer, but the link Prostate reduction is neither confirmed nor clear. Medication Some prostate reduction research has suggested that non-steroidal anti-inflammatory drug (NSAID) use may reduce the risk of prostate cancer. Others have linked NSAID use with a higher risk of death from the disease. This is a controversial area, and results have not been confirmed. There has also been some investigation into whether statins might slow prostate reduction the progression of prostate cancer.
One 2016 Prostate reduction study concluded that results were "weak and inconsistent." Obesity It is often believed that obesity prostate reduction is linked to the development of prostate cancer, but the American Cancer Society maintains that there is no clear link. Some studies have found that obesity increases the risk prostate reduction of death in advanced cancers. Studies have also Prostate reduction concluded that obesity decreases the risk that a cancer will be low-grade if it does occur. Agent Orange Exposure to Agent Orange, a chemical weapon used in the Vietnam war, may possibly be linked to the development prostate reduction of more aggressive types of cancer, but the extent of this has not been confirmed. This condition is known as Benign Prostatic Hyperplasia (or prostate adenoma) because it refers to the non-malignant growth of prostatic tissue Prostate reduction in men from middle age onwards. In a prostate reduction Prostate reduction young man, the prostate gland is at an almost undetectable rudimentary stage, and spreads across the coating of the urinary tract like prostate reduction a cluster of seeds. However, during puberty, its form begins to change due to the increased production of the testosterone and dihydrotestosterone hormones. Testosterone causes the "seeds", called acini, Prostate reduction to germinate and grow. In adult life, due to this growth and proliferation, these small Prostate reduction glandular structures can give rise to obstructive symptoms associated with urinary flow disorders. Benign Prostatic Hyperplasia is one of the most common diseases in men and is considered to be part of the physiological ageing process. The incidence of this disease is 51% in Prostate reduction men aged 60 to 69, and between 75% and 90% in octogenarians. Symptomatology Although the prostate reduction definition of BPH encapsulates the enlargement of the prostate and the mechanical obstruction of the flow of urine, a direct relationship between the volume of hyperplasia and the intensity of symptoms is not always present. Very enlarged prostates do not always cause symptoms and prostate reduction other less enlarged organs can be a source of intense discomfort. The symptoms of Benign Prostatic Hyperplasia can be divided into two categories: obstructive and irritative. Obstructive symptoms Weak and/or intermittent flow of urine. Double voiding (urinating Prostate reduction for a second time within a period of 2 hours).
Irritative symptoms Polyuria, or increased frequency of urination.
Nocturia, or the need to urinate frequently during the night. Treatment of Benign Prostatic Hyperplasia Early diagnosis of Benign prostate reduction Prostatic Hyperplasia is essential to avoid complications such as urinary tract infections, damage to Prostate reduction the kidneys or bladder, bladder stones and incontinence. The Prostate reduction treatment for BPH will be determined by the potential for the existence of prostate reduction these secondary processes that derive from urinary obstruction, along with the patient’s level of discomfort prostate reduction Prostate reduction Medical treatment In patients with mild or moderate Symptoms, a pharmacological treatment can be administered that is based on alpha-blockers and alpha-reductase inhibitors, which can help to improve urinary flow.
Prostate adenoma pathology outlines
Gleason 9 prostate cancer survival rates
Male prostate g
Prostatitis or prostate cancer
| 23.05.2018 - Aylin_05 |
| Between 75% and 90% while men who continued (current smokers) did. |
| 23.05.2018 - Dj_SkypeGirl |
| In a young man, the prostate gland. |
| 23.05.2018 - EMOS |
| Cancer staging, and urologist (a doctor who specializes in diseases of the urinary tract there was no change in relative. |
No comments:
Post a Comment